A Gene Variant in IRF3 Impacts On the Clinical Outcome of Acute Myeloid Leukemia (AML) Patients Submitted to Allogeneic Stem Cell Transplantation (allo-SCT)

被引：0
|
作者：
Martin-Antonio, Beatriz
Suarez-LLedo, Maria
Arroyes, Montserrat
Fernandez-Aviles, Francesc [1 ]
Martinez, Carmen
Rovira, Montserrat
Espigado, Ildefonso [2 ]
Gallardo, David [3 ]
Bosch, Anna [4 ]
Buno, Ismael [5 ]
Martinez-Laperche, Carolina [6 ]
Jimenez-Velasco, Antonio [7 ]
De La Camara, Rafael [8 ]
Brunet, Salut [9 ]
Nieto, Jose B. [10 ]
Urbano-Ispizua, Alvaro [11 ]
机构：
[1] Hosp Clin Barcelona, Barcelona, Spain
[2] Hosp Univ Virgen del Rocio, Seville, Spain
[3] ICO Hosp Josep Trueta, Girona, Spain
[4] Hosp Josep Trueta, Girona, Spain
[5] Gregorio Maranon Hlth Res Inst IISGM, Madrid, Spain
[6] Gregorio Maranon Gen Univ Hosp, Dept Hematol, Madrid, Spain
[7] Hosp Carlos Haya, Malaga, Spain
[8] Hosp Univ De La Princesa, Madrid, Spain
[9] Hosp Santa Creu & Sant Pau, Barcelona, Spain
[10] Hosp Morales Meseguer, Murcia, Spain
[11] IDIBAPS, Hosp Clin, Inst Hematol & Oncol, Barcelona, Spain
来源：
BLOOD | 2012年 / 120卷 / 21期
关键词：
D O I：
10.1182/blood.V120.21.468.468
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
468
引用
下载
收藏
页数：2
相关论文
共 50 条
  • [31] Sequential Chemotherapy Followed by Reduced Intensity Conditioning and Allogeneic Stem Cell Transplantation (allo-SCT) in Adult Patients with Relapsed or Refractory Acute Myeloid Leukemia (AML): A Survey From the Acute Leukemia Working Party of EBMT
    Ringden, Olle
    Labopin, Myriam
    Kolb, Hans Jochem
    Michallet, Mauricette
    Kroeger, Nicolaus
    Ganser, Arnold
    Bunjes, Donald
    Hallek, Michael
    Kanz, Lothar
    Schwerdtfeger, Rainer
    Holler, Ernst
    Arnold, Renate
    Huynh, Anne
    Nagler, Arnon
    Schmid, Christoph
    Mohty, Mohamad
    BLOOD, 2012, 120 (21)
  • [32] Association between the polycomb group (PcG) BMI-1 gene expression and outcome in chronic myeloid leukemia (CML) patients receiving allogeneic stem cell transplantation (allo-SCT)
    Mohty, Mohamad
    Yong, Agnes S. M.
    Szydlo, Richard M.
    Apperley, Jane F.
    Goldman, John M.
    Melo, Junin V.
    BLOOD, 2007, 110 (11) : 143A - 143A
  • [33] Optimal Timing of Allogeneic Stem Cell Transplantation (Allo-SCT) for Chronic Myeloid Leukemia (CML) Patients in the Tyrosine Kinase Inhibitor (TKI) Era
    Hu, Bei
    Lin, Xiao
    Lee, Hans C.
    Huang, Xuelin
    Slack, Rebecca
    Jabbour, Elias J.
    Verstovsek, Srdan
    Ravandi, Farhad
    Garcia-Manero, Guillermo
    Champlin, Richard E.
    Hu, Zhen-Huan
    Ahn, Kwang Woo
    Lee, Ying
    Popat, Uday
    Sobecks, Ronald
    Alyea, Edwin
    Kantarjian, Hagop M.
    Cortes, Jorge E.
    Saber, Wael
    BLOOD, 2017, 130
  • [34] Outcomes of Allogeneic Stem Cell Transplant (Allo-SCT) for Acute Myeloid Leukemia (AML) and Myelodysplastic Syndromes (MDS) in Patients Older Than 75 Years: A Single Center Analysis
    Nath, Rajneesh
    Cerny, Jan
    Ramanathan, Muthalagu
    Zhou, Zheng
    Yu, Neng
    Raffel, Glen D.
    Bednarik, Jayde
    BLOOD, 2016, 128 (22)
  • [35] Impact of plasmacytoid dendritic cell (PDC) recovery on outcome after allogeneic stem cell transplantation (allo-SCT).
    Mohty, M
    Blaise, D
    Faucher, C
    Olive, D
    Gaugler, R
    CLINICAL IMMUNOLOGY, 2005, 115 : S28 - S29
  • [36] IMPACT OF CYTOGENETICS RISK ON OUTCOME AFTER REDUCED INTENSITY CONDITIONING (RIC) ALLOGENEIC STEM CELL TRANSPLANTATION (ALLO-SCT) FROM AN HLA IDENTICAL SIBLING FOR PATIENTS WITH ACUTE MYELOID LEUKEMIA (AML) IN FIRST COMPLETE REMISSION (CRI)
    Mobty, M.
    Labopin, M.
    Milpied, N.
    Cornelissen, J. J.
    Blaise, D.
    Petersen, E.
    Theorin, N.
    Goker, H.
    Socie, G.
    Rocha, V
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2009, 15 (02) : 21 - 21
  • [37] SERIOUS EBV ENCEPHALITIS IN PATIENTS AFTER ALLOGENEIC STEM CELL TRANSPLANTATION (ALLO-SCT) - SERIES OF 3 CASES
    Kouba, M.
    Markova, M.
    Valkova, V.
    Hricinova, M.
    Soukup, P.
    Salek, C.
    Mertova, J.
    Maaloufova, J.
    Hubacek, P.
    Cermak, J.
    Vitek, A.
    Cetkovsky, P.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2009, 94 : 413 - 413
  • [38] Activity and Tolerability of Azacitidine in Patients Who Relapse after Allogeneic Stem Cell Transplantation (allo-SCT) for Acute Myeloid Leukemia (AML) and Myelodysplasia (MDS): a Survey from the European Society for Blood and Marrow Transplantation (EBMT
    Craddock, Charles
    Labopin, Myriam
    Houhou, Mohamed
    Robin, Marie
    Finke, Juergen
    Chevallier, Patrice
    Yakoub-Agha, Ibrahim
    Bourhis, Jean-Henri
    Sengelov, Henrik
    Blaise, Didier
    Dreger, Peter
    Hallek, Michael
    Nagler, Arnon
    Kroger, N.
    Mohty, Mohamad
    BLOOD, 2014, 124 (21)
  • [39] Allogeneic Stem Cell Transplantation (Allo-SCT) for De Novo Ph plus Acute Myeloid Leukemia: A Study from the French Society of Bone Marrow Transplantation and Cell Therapies
    Chantepie, Sylvain P.
    Michallet, Mauricette
    Blaise, Didier
    Maury, Sebastien
    Deconinck, Eric
    Tabrizi, Reza
    Contentin, Nathalie
    Mohty, Mohamad
    Nguyen, Stephanie
    Lioure, Bruno
    Raus, Nicole
    de Latour, Regis Peffault
    Yakoub-Agha, Ibrahim
    Reman, Oumedaly
    BLOOD, 2014, 124 (21)
  • [40] Extramedullary Relapses after Allogeneic Stem Cell Transplant (allo-SCT) in Adult Patients with Acute Lymphoblastic Leukemia (ALL)
    Shimizu, Hiroaki
    Ishizaki, Takuma
    Hatsumi, Nahoko
    Takada, Satoru
    Yokohama, Akihiko
    Saitoh, Takayuki
    Sakura, Toru
    Handa, Hiroshi
    BLOOD, 2019, 134
12345